National Comprehensive Cancer Network Updates Annual Conference with New In-Person Venue, Hybrid Format, Expert-Led Sessions, Highlighted Research Perspectives, and Small-Group Conversations
Annual conference featuring more than a thousand worldwide oncology professionals will present new research findings, latest NCCN Guidelines updates, and best practices achieving quality cancer care delivery, in Orlando March 31—April 2, 2023. PLYMOUTH MEETING, Pa., March 1, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) today announced the NCCN 2023 Annual...
FIRST CLINICAL EVIDENCE PUBLISHED ON AROA’s ENIVO™ SYSTEM FOR SURGICAL DEAD SPACE MANAGEMENT.
AUCKLAND, New Zealand, Aug. 27, 2025 /PRNewswire/ -- AROA is pleased to announce the findings of the first in human study involving its new ENIVO platform technology. The study is the subject of a peer-reviewed publication entitled Prospective, First-in-Human Clinical Evaluation of a Novel Tissue Apposition Device (ENIVO™) Following Simple Unilateral Mastectomy, which was published in the well-respected journal, Plastic and...
WuXi Biologics Recognized as 2022 Top-Rated ESG Company by Sustainalytics
SHANGHAI, March 14, 2022 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global CRDMO service company, has been recognized as the Industry Top-Rated Company in 2022 by Sustainalytics, a global provider of Environmental, Social and Governance (ESG) related research, ratings and data. This is the second year in a row that WuXi Biologics has received this recognition. Sustainalytics' ESG Risk Ratings...
Infinitus Highlights Modernizing Traditional Prescriptions at ICMCM
GUANGZHOU, China, Aug. 20, 2024 /PRNewswire/ -- Recently, the highly-anticipated 23rd International Conference of the Modernization of Chinese Medicine & Health Products (ICMCM) took place in Hong Kong, bringing together global experts, top researchers and industry leaders in traditional medicine. The gathering fostered robust online and offline interactions, centering its discourse on the theme of "Industry-University-Research Collaboration and...
For the First time in Thailand! Chulalongkorn University Researchers Found a “Glowing Land Snail”
BANGKOK, July 24, 2024 /PRNewswire/ -- Chulalongkorn University researchers have discovered Thailand's first glowing land snail and the first one in the world in the last 80 years. Preparations are underway to decode its genetics paving the way to expand medical research and scientific knowledge. For the First time in Thailand! Chulalongkorn University Researchers Found...
Akeso’s Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
HONG KONG, Sept. 16, 2024 /PRNewswire/ -- At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a first-line (1L) treatment for triple-negative breast cancer (TNBC). The preliminary data, with only a 10-month median follow-up, revealed that the ivonescimab combination regimen demonstrated excellent...
A New University Science Park of Neusoft Institute Guangdong to Foster Innovation in Cross-sector Development
HONG KONG, March 1, 2025 /PRNewswire/ -- Neusoft Institute Guangdong, a member of Neutech Group Limited, has successfully acquired the land use rights for a new 140,000-square-meter plot in Nanhai District, Foshan City, Guangdong Province, through a public bidding process. Aligned with the Group's integrated "education healthcare wellness and mind tour" strategy, the school closely followed the needs of...
AXA and Prosper Health introduce pioneering dedicated cancer case management service in Greater Bay Area[1]
Partners with Prosper Healthintroducing "Greater Bay Area Cancer Medical Concierge Service Network" HONG KONG, Jan. 21, 2025 /PRNewswire/ -- AXA Hong Kong and Macau ("AXA") announces a partnership with Prosper Health, a member-centric health insurance service provider under New Frontier Group - one of China's leading integrated private healthcare service institutions, to launch premium cross-border medical support services for eligible AXA customers, to further...
Akeso’s 2024 First Half Interim Results: Expanding Global Lead in IO Bispecific Antibodies, Advancing New Therapies, and Accelerating Commercialization
Approval of ivonescimab for 2L+ EGFRm NSCL; HARMONi-A is the only phase III study that demonstrates significant benefit across all subgroups for PFS, and is also the only study to achieve the primary endpoint while showing a positive trend in OS benefit; HARMONi-A study presented in an oral presentation at ASCO 2024 and published in JAMA. Ivonescimab...
A*STAR and Flagship Pioneering Announce Partnership to Spur Biotech Innovation in Singapore
Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent Development SINGAPORE, Oct. 3, 2024 /PRNewswire/ -- The Agency for Science, Technology and Research (A*STAR), Singapore's lead public sector R&D agency, and Flagship Pioneering, the bioplatform innovation company, today announced plans to collaborate to...
